Mechanisms of dyslipoproteinemias in systemic lupus erythematosus
2006
Understanding Lipid Changes in Lupus
publication
Evidence: moderate
Author Information
Author(s): EDUARDO F. BORBA, JOZELIO F. CARVALHO, ELOI SA BONFA
Primary Institution: Rheumatology Division, Sao Paulo University Medical School Hospital, Sao Paulo, SP, Brazil
Hypothesis
The interaction of disease-associated factors induces specific alterations in lipoprotein metabolism in systemic lupus erythematosus (SLE).
Conclusion
SLE is associated with a 'lupus pattern' of dyslipoproteinemia characterized by high levels of triglycerides and low levels of HDL, which may contribute to increased cardiovascular risk.
Supporting Evidence
- SLE patients often have low HDL levels, which are linked to heart disease risk.
- High triglyceride levels in lupus patients are associated with disease activity.
- Autoantibodies in lupus may worsen lipid metabolism.
- Inflammatory cytokines can reduce lipoprotein lipase activity, affecting lipid levels.
Takeaway
People with lupus have different fat levels in their blood that can make their hearts sick. This happens because of the disease and some medicines they take.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website